Author: kjt5j@virginia.edu

SAMHSA: National Center of Excellence for Integrated Health Solutions

2/8/2019

Purpose The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Mental Health Services (CMHS) is accepting applications for fiscal year (FY) 2019 National Center of Excellence for Integrated…

Department of Defense – FY19 Pre-announcement of the Tuberous Sclerosis Complex Research Program (TSCRP)

2/7/2019

If  you wish to speak with The Conafay Group about developing a proposal for this program, please contact Dr. David Driscoll (dld5dt). The Department of Defense recently released a pre-announcement for…

NIH – Progression Markers for Cognitive Impairment in Parkinson’s Disease Dementia (R01 Clinical Trial Not Allowed)

2/7/2019

In 2011, the National Alzheimer's Project Act (NAPA) allocated resources "to prevent and effectively treat Alzheimer's by 2025."  Since then, the National Institute on Aging (NIA) and the National Institute of…

NIH – Development and Validation of Advanced Mammalian Models for Alzheimer’s Disease-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed)

2/7/2019

Alzheimer'sdisease-related dementias (ADRD) are a group of progressive, neurodegenerative disorders with mid- to late-life onset, including Lewy body dementia (LBD), vascular contributions to cognitive impairment and dementia (VCID), frontotemporal degeneration…

NIH – Implementation of shared decision making for HLBS diseases and conditions (R01 Clinical Trial Optional)

2/7/2019

The purpose of this new FOA is to support research that uses evidence-based, practical approaches to increase the uptake of shared decision making (SDM) into routine clinical practice. Proposed projects…

NIH – Botanical Dietary Supplements Research Centers (BDSRC) (U19 Clinical Trial Optional)

2/7/2019

Plants and plant-derived products are widely consumed for basic nutrition, and to promote health and well-being, worldwide and in the U.S. Nevertheless, there is only a partial understanding of what…

NIH/NHLBI – NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)

2/7/2019

The purpose of the NHLBI Emerging Investigator Award (EIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PD/PIs) who…

NIH/NHLBI – NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)

2/7/2019

The purpose of the NHLBI Outstanding Investigator Award (OIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Director/Principal Investigators (PD/PIs) who…

NIH/NIDDK – Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Obesity Research (U01 Clinical Trial Not Allowed)

2/7/2019

Many assays in basic and clinical science research rely exclusively on antibodies. However, there are no widely accepted guidelines or standardized methods to determine the validity of these reagents. Furthermore,…

NIH/NIDDK – Establishing a Cohort to Clarify Risk and Protective Factors for Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) – Planning Cooperative Agreements (U34 Clinical Trial Not Allowed)

2/7/2019

There is growing evidence that there are neurocognitive complications of T1D, with approximately 28% of middle aged adults and 48% of older adults meeting criteria for clinically significant cognitive impairment…